Awake Axillary Impella 5.5 Placement - A Feasibility Trial
Cardiogenic Shock
About this trial
This is an interventional treatment trial for Cardiogenic Shock focused on measuring Impella 5.5, Cardiogenic shock, PECS II, Interscalene, Superficial Cervical, regional anesthesia
Eligibility Criteria
Inclusion Criteria: Baseline Criteria: Agrees to procedure Excellent ultrasound images for nerve blocks Excellent ultrasound images for trans thoracic echo Age <60, BMI <30 Non hostile neck Evaluation of CT amenable to easy surgical access for Impella placement Meets criteria for MAC sedation: Able to lay relatively flat comfortably Able to understand and cooperate with procedures Easy airway (Mallampati I - II, prior grade 1-2 airway) Low risk of airway obstruction No high baseline oxygen requirement (over 6L/min) Meets criteria for regional anesthesia: Patient agrees to nerve block No active areas of infection around the block site No history of nerve damage or deficits in the area of the proposed nerve block No contralateral diaphragmatic paralysis or phrenic nerve palsy Exclusion Criteria: Does not wish to have MAC Does not wish to have Regional Anesthesia BMI > 30 Poor U/S windows for block or TTE Active infection over block area High Oxygen Requirement >6L NC Known or anticipated difficult airway Unable to lay flat comfortably Unable to cooperate or follow instructions
Sites / Locations
- Hospital of the University of Pennsylvania
- Penn Presbyterian Medical Center
Arms of the Study
Arm 1
Experimental
Treatment Arm
Patient in cardiogenic shock listed for Impella 5.5 placement who meets study inclusion criteria